BlackRock Advisors’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $54K | Hold |
21,319
| – | – | ﹤0.01% | 3162 |
|
|
2016
Q3 | $66K | Buy |
21,319
+3,501
| +20% | +$10.8K | ﹤0.01% | 3104 |
|
|
2016
Q2 | $57K | Buy |
17,818
+262
| +1% | +$838 | ﹤0.01% | 3142 |
|
|
2016
Q1 | $54K | Hold |
17,556
| – | – | ﹤0.01% | 3091 |
|
|
2015
Q4 | $70K | Sell |
17,556
-8,787
| -33% | -$35K | ﹤0.01% | 3032 |
|
|
2015
Q3 | $121K | Buy |
26,343
+1,419
| +6% | +$6.52K | ﹤0.01% | 2966 |
|
|
2015
Q2 | $129K | Buy |
24,924
+1,573
| +7% | +$8.14K | ﹤0.01% | 3021 |
|
|
2015
Q1 | $146K | Buy |
23,351
+2,350
| +11% | +$14.7K | ﹤0.01% | 2833 |
|
|
2014
Q4 | $132K | Sell |
21,001
-771
| -4% | -$4.85K | ﹤0.01% | 2856 |
|
|
2014
Q3 | $132K | Sell |
21,772
-374
| -2% | -$2.27K | ﹤0.01% | 2822 |
|
|
2014
Q2 | $146K | Buy |
22,146
+626
| +3% | +$4.13K | ﹤0.01% | 2801 |
|
|
2014
Q1 | $512K | Buy |
21,520
+1,317
| +7% | +$31.3K | ﹤0.01% | 2005 |
|
|
2013
Q4 | $216K | Buy |
20,203
+1,611
| +9% | +$17.2K | ﹤0.01% | 2593 |
|
|
2013
Q3 | $248K | Sell |
18,592
-8
| -0% | -$107 | ﹤0.01% | 2395 |
|
|
2013
Q2 | $244K | Buy |
+18,600
| New | +$244K | ﹤0.01% | 2350 |
|